Determination of selected pharmaceuticals in tap water and drinking water treatment plant by high-performance liquid chromatography-triple quadrupole mass spectrometer in Beijing, China

Environmental Science and Pollution Research

Volumn 22, Issue 3, 2015, Pages 1854-1867

  Cai, Mei Quan ^a   Wang, Rong ^a   Feng, Li ^a   Zhang, Li Qiu ^a  

^a BEIJING FORESTRY UNIVERSITY   (China)

Author keywords

DWTP; HPLC MS MS; Pharmaceuticals; Tap water

Indexed keywords

CONCENTRATION (COMPOSITION); DRINKING WATER; DRUG; LIQUID CHROMATOGRAPHY; WATER TREATMENT;

BEIJING [CHINA]; CHINA;

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; DRINKING WATER; DRUG; WATER POLLUTANT;

ANALYSIS; CHINA; CITY; ENVIRONMENTAL MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PROCEDURES; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WATER MANAGEMENT; WATER POLLUTANT; WATER SUPPLY;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTICONVULSANTS; CHINA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITIES; DRINKING WATER; ENVIRONMENTAL MONITORING; HYPOLIPIDEMIC AGENTS; PHARMACEUTICAL PREPARATIONS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION; WATER SUPPLY;

EID: 84921932458     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-014-3473-8     Document Type: Article

References (40)

1. Acero JL, Benitez FJ, Real FJ, Roldan G (2010) Kinetics of aqueous chlorination of some pharmaceuticals and their elimination from water matrices. Water Res 44(14):4158–4170. doi:10.1016/j.watres.2010.05.012
2. Antignac J-P, de Wasch K, Monteau F, De Brabander H, Andre F, Le Bizec B (2005) The ion suppression phenomenon in liquid chromatography–mass spectrometry and its consequences in the field of residue analysis. Anal Chim Acta 529(1–2):129–136. doi:10.1016/j.aca.2004.08.055
3. Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA (2009) Pharmaceuticals and endocrine disrupting compounds in U.S. drinking water. Environ Sci Technol 43(3):597–603. doi:10.1021/es801845a
4. Boleda MA, Galceran MA, Ventura F (2011) Behavior of pharmaceuticals and drugs of abuse in a drinking water treatment plant (DWTP) using combined conventional and ultrafiltration and reverse osmosis (UF/RO) treatments. Environ Pollut 159(6):1584–1591. doi:10.1016/j.envpol.2011.02.051
5. Bu Q, Wang B, Huang J, Deng S, Yu G (2013) Pharmaceuticals and personal care products in the aquatic environment in China: a review. J Hazard Mater 262C:189–211. doi:10.1016/j.jhazmat.2013.08.040
6. Cai MQ, Feng L, Jiang J, Qi F, Zhang LQ (2013) Reaction kinetics and transformation of antipyrine chlorination with free chlorine. Water Res 47(8):2830–2842. doi:10.1016/j.watres.2013.02.047
7. Cleuvers M (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142(3):185–194. doi:10.1016/s0378-4274(03)00068-7
8. Deborde M, Rabouan S, Gallard H, Legube B (2004) Aqueous chlorination kinetics of some endocrine disruptors. Environ Sci Technol 38(21):5577–5583
9. Dodd MC, Huang CH (2004) Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: kinetics, mechanisms, and pathways. Environ Sci Technol 38(21):5607–5615
10. Heberer T, Mechlinski A, Fanck B, Knappe A, Massmann G, Pekdeger A, Fritz B (2004) Field studies on the fate and transport of pharmaceutical residues in bank filtration. Ground Water Monit R 24(2):70–77. doi:10.1111/j.1745-6592.2004.tb00714.x
11. Kim SD, Cho J, Kim IS, Vanderford BJ, Snyder SA (2007) Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 41(5):1013–1021. doi:10.1016/j.watres.2006.06.034
12. Kosma CI, Lambropoulou DA, Albanis TA (2010) Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J Hazard Mater 179(1–3):804–817. doi:10.1016/j.jhazmat.2010.03.075
13. Mompelat S, Le Bot B, Thomas O (2009) Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ Int 35(5):803–814. doi:10.1016/j.envint.2008.10.008
14. Mompelat S, Thomas O, Le Bot B (2011) Contamination levels of human pharmaceutical compounds in French surface and drinking water. J Environ Monit 13(10):2929–2939. doi:10.1039/c1em10335k
15. Nikolaou A, Meric S, Fatta D (2007) Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal Bioanal Chem 387(4):1225–1234. doi:10.1007/s00216-006-1035-8
16. Reddersen K, Heberer T, Dunnbier U (2002) Identification and significance of phenazone drugs and their metabolites in ground- and drinking water. Chemosphere 49(6):539–544
17. Richardson ML, Bowron JM (1985) The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 37(1):1–12
18. Rodil R, Quintana JB, Cela R (2012a) Transformation of phenazone-type drugs during chlorination. Water Res 46(7):2457–2468. doi:10.1016/j.watres.2012.02.018
19. Rodil R, Quintana JB, Concha-Grana E, Lopez-Mahia P, Muniategui-Lorenzo S, Prada-Rodriguez D (2012b) Emerging pollutants in sewage, surface and drinking water in Galicia (NW Spain). Chemosphere 86(10):1040–1049. doi:10.1016/j.chemosphere.2011.11.053
20. Rosa Boleda M, Huerta-Fontela M, Ventura F, Galceran MT (2011) Evaluation of the presence of drugs of abuse in tap waters. Chemosphere 84(11):1601–1607. doi:10.1016/j.chemosphere.2011.05.033
21. Simazaki D, Fujiwara J, Manabe S, Matsuda M, Asami M, Kunikane S (2008) Removal of selected pharmaceuticals by chlorination, coagulation-sedimentation and powdered activated carbon treatment. Water Sci Technol 58(5):1129–1135. doi:10.2166/wst.2008.472
22. Soufan M, Deborde M, Legube B (2012) Aqueous chlorination of diclofenac: kinetic study and transformation products identification. Water Res 46(10):3377–3386. doi:10.1016/j.watres.2012.03.056
23. Stackelberg PE, Furlong ET, Meyer MT, Zaugg SD, Henderson AK, Reissman DB (2004) Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci Total Environ 329(1–3):99–113. doi:10.1016/j.scitotenv.2004.03.015
24. Stackelberg PE, Gibs J, Furlong ET, Meyer MT, Zaugg SD, Lippincott RL (2007) Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci Total Environ 377(2–3):255–272. doi:10.1016/j.scitotenv.2007.01.095
25. Sui Q, Huang J, Deng S, Yu G (2010a) Rapid determination of pharmaceuticals from multiple therapeutic classes in wastewater by solid-phase extraction and ultra-performance liquid chromatography tandem mass spectrometry. Chin Sci Bull 54(24):4633–4643. doi:10.1007/s11434-009-0413-y
26. Sui Q, Huang J, Deng S, Yu G, Fan Q (2010b) Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Res 44(2):417–426. doi:10.1016/j.watres.2009.07.010
27. Ternes TA, Meisenheimer M, Mcdowell D, Sacher F, Brauch H-J, Preuss G, Wilme U, Zulei-Seibert N (2002) Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 36:3855–3863
28. Togola A, Budzinski H (2008) Multi-residue analysis of pharmaceutical compounds in aqueous samples. J Chromatogr A 1177(1):150–158. doi:10.1016/j.chroma.2007.10.105
29. Vieno NM, Tuhkanen T, Kronberg L (2005) Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 39(21):8220–8226
30. Vieno N, Tuhkanen T, Kronberg L (2006) Removal of pharmaceuticals in drinking water treatment: effect of chemical coagulation. Environ Technol 27(2):183–192. doi:10.1080/09593332708618632
31. Vieno NM, Härkki H, Tuhkanen T, Kronberg L (2007) Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ Sci Technol 41(14):5077–5084. doi:10.1021/es062720x
32. Wang L, Ying GG, Zhao JL, Yang XB, Chen F, Tao R, Liu S, Zhou LJ (2010) Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. Sci Total Environ 408(16):3139–3147. doi:10.1016/j.scitotenv.2010.04.047
33. Westerhoff P (2003) Removal of endocrine disruptors, pharmaceuticals and personal care products during water treatment. Southwest Hydrol 2(6):18–19
34. Xagoraraki I, Hullman R, Voice T, Song W, Li H (2008) Effect of pH on degradation of acetaminophen and production of 1,4-benzoquinone in water chlorination. J Water Supply Res T 57(6):381. doi:10.2166/aqua.2008.095
35. Yang Y, Fu J, Peng H, Hou L, Liu M, Zhou JL (2011) Occurrence and phase distribution of selected pharmaceuticals in the Yangtze Estuary and its coastal zone. J Hazard Mater 190(1–3):588–596. doi:10.1016/j.jhazmat.2011.03.092
36. Yang X, Chen F, Meng F, Xie Y, Chen H, Young K, Luo W, Ye T, Fu W (2013) Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China. Environ Sci Pollut Res Int 20(8):5864–5875. doi:10.1007/s11356-013-1641-x
37. Zhao JL, Ying GG, Liu YS, Chen F, Yang JF, Wang L (2010a) Occurrence and risks of triclosan and triclocarban in the Pearl River system, South China: from source to the receiving environment. J Hazard Mater 179(1–3):215–222. doi:10.1016/j.jhazmat.2010.02.082
38. Zhao JL, Ying GG, Liu YS, Chen F, Yang JF, Wang L, Yang XB, Stauber JL, Warne MS (2010b) Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China. Environ Toxicol Chem 29(6):1377–1384. doi:10.1002/etc.161
39. Zhu S, Chen H, Li J (2013) Sources, distribution and potential risks of pharmaceuticals and personal care products in Qingshan Lake basin, Eastern China. Ecotoxicol Environ Saf 96:154–159. doi:10.1016/j.ecoenv.2013.06.033
40. Zuhlke S, Dunnbier U, Heberer T (2004) Detection and identification of phenazone-type drugs and their microbial metabolites in ground and drinking water applying solid-phase extraction and gas chromatography with mass spectrometric detection. J Chromatogr A 1050(2):201–209